Report Overview:
The Global Bio Pharmaceuticals Market achieved a valuation of $326.01 Billion in 2022 and is anticipated to exceed $668.92 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 9.4% during the forecast period from 2024 to 2032.
Key Market Players:
Abbott Laboratories Amgen Inc., Biogen Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd.,...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek